Increased isoform-specific phosphodiesterase 4D expression is associated with pathology and cognitive impairment in Alzheimer’s disease-Reference-Cited by-同舟云学术

Increased isoform-specific phosphodiesterase 4D expression is associated with pathology and cognitive impairment in Alzheimer’s disease

Published:2021-01 Issue: Volume:97 Page:56-64
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Paes Dean,Lardenoije Roy,Carollo Riccardo M.,Roubroeks Janou A.Y.,Schepers Melissa,Coleman Paul,Mastroeni Diego,Delvaux Elaine^ORCID,Pishva Ehsan,Lunnon Katie,Vanmierlo Tim,van den Hove Daniel,Prickaerts Jos

Funder

ISAO/Alzheimer Nederland

Young European Research Universities Network

Internationale Stichting Alzheimer Onderzoek

Dorpmans-Wigmans Foundation

Joint Programme–Neurodegenerative Disease Research

The Netherlands Organisation for Health Research and Development

German Federal Ministry of Education and Research

European Union’s Horizon

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Clinical Neurology,Ageing,General Neuroscience

Reference63 articles.

1. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays;Aryee;Bioinformatics (Oxford, England),2014

2. Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays;Baillie;Biochem. J.,2007

3. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi;Baillie;Proc. Natl. Acad. Sci. U. S. A.,2003

4. PDE4D regulates spine plasticity and memory in the retrosplenial cortex;Baumgartel;Sci. Rep.,2018

5. Arizona Study of Aging and Neurodegenerative disorders and brain and body donation program;Beach;Neuropathology,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system;Biomedicine & Pharmacotherapy;2024-08

2. PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE;INDIAN DRUGS;2024-07-28

3. Amelioration of functional and histopathological consequences after spinal cord injury through phosphodiesterase 4D (PDE4D) inhibition;Neurotherapeutics;2024-07

4. Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases;Journal of Zhejiang University (Medical Sciences);2024-06-01

5. Beta‐amyloid interacts with and activates the long‐form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability;FEBS Letters;2024-05-09